4//SEC Filing
Curran Daniel J. 4
Accession 0001415889-25-016969
CIK 0001840233other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:36 PM ET
Size
5.5 KB
Accession
0001415889-25-016969
Insider Transaction Report
Form 4
Curran Daniel J.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-11+31,000→ 31,000 totalExercise: $0.69Exp: 2035-06-10→ Common Stock (31,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 11, 2025 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 11, 2026 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001887599
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:36 PM ET
- Size
- 5.5 KB